The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroup.
Renaghan AD, Ostermann M, Ronco C, Ballen K, Cosmai L, Fenoglio R, Floris M, Forni LG, Gladstone DE, Glezerman IG, Goldstein SL, Gupta S, Herrmann SM, Jaimes EA, Jhaveri KD, Karam S, Kitchlu A, Landau HJ, Latcha S, Leaf DE, Lentini P, Małyszko J, Markowitz G, Murakami N, Pani A, Perazella MA, Rashidi A, Roccatello D, Sharon E, Sprangers B, Tesař V, Torres V, Wanchoo R, Whitman A, Workeneh BT, Zepeda-Orozco D, Rosner MH.
Renaghan AD, et al.
Nat Rev Nephrol. 2026 Apr;22(4):283-300. doi: 10.1038/s41581-025-01031-3. Epub 2025 Dec 8.
Nat Rev Nephrol. 2026.
PMID: 41361704
Review.